Literature DB >> 29411897

The immunopathogenic and immunomodulatory effects of interleukin-12 in periodontal disease.

Benjar Issaranggun Na Ayuthaya1,2, Vincent Everts3, Prasit Pavasant2,4.   

Abstract

Interleukin 12 (IL-12) is an inflammatory cytokine that promotes the response of the immune system. This cytokine has been implicated as a potent stimulator of several diseases characterized by inflammatory-induced bone destruction, such as rheumatoid arthritis and periodontitis. Yet, the exact role of IL-12 in the development and progress of periodontitis has not been clarified. Several studies have demonstrated a positive correlation between the level of IL-12 and the severity of periodontal destruction. Deletion of IL-12 in mice with periodontitis significantly suppressed the level of bone destruction. Interestingly, next to a role in modulating the pathogenesis, IL-12 also has immunological-regulatory properties. This cytokine induces expression of immunosuppressive molecules, such as indoleamine-pyrrole 2,3-dioxygenase (IDO). Thus, these findings suggest both negative and positive influences of IL-12 in periodontal disease. It is currently proposed that the diversity of action of cytokines is a molecular key which regulates biological development and homeostasis. Accordingly, the actions of IL-12 might be one of the mechanisms that regulate homeostasis of periodontal tissue during and following inflammation. Therefore, this article aims to review both destructive and protective functionalities of IL-12 with an emphasis on periodontal disease.
© 2018 Eur J Oral Sci.

Entities:  

Keywords:  bone remodeling; immunomodulation; inflammation; interleukin-12; periodontal disease

Mesh:

Substances:

Year:  2018        PMID: 29411897     DOI: 10.1111/eos.12405

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  7 in total

1.  Tapping basement membrane motifs: Oral junctional epithelium for surface-mediated soft tissue attachment to prevent failure of percutaneous devices.

Authors:  Nicholas G Fischer; Alexandra C Kobe; Jinhong Dai; Jiahe He; Hongning Wang; John A Pizarek; David A De Jong; Zhou Ye; Shengbin Huang; Conrado Aparicio
Journal:  Acta Biomater       Date:  2021-12-29       Impact factor: 8.947

Review 2.  Deciphering desirable immune responses from disease models with resistant and susceptible chickens.

Authors:  Leon J Broom; Michael H Kogut
Journal:  Poult Sci       Date:  2019-04-01       Impact factor: 3.352

3.  Identification of the key differentially expressed genes and pathways involved in neutrophilia.

Authors:  Chengcheng He; Yingchun Zhang; Hongwei Luo; Bo Luo; Yancheng He; Nan Jiang; Yu Liang; Jingyuan Zeng; Yujiao Luo; Yujun Xian; Jiajia Liu; Xiaoli Zheng
Journal:  Innate Immun       Date:  2019-11-15       Impact factor: 2.680

Review 4.  Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.

Authors:  Lina J Suárez; Hernan Garzón; Silie Arboleda; Adriana Rodríguez
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

5.  Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population.

Authors:  Eftychia Pappa; Heleni Vastardis; George Mermelekas; Andriani Gerasimidi-Vazeou; Jerome Zoidakis; Konstantinos Vougas
Journal:  Front Physiol       Date:  2018-04-26       Impact factor: 4.566

6.  Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.

Authors:  Jing Ye; Ying Huang; Bin Que; Chao Chang; Wenjing Liu; Haiying Hu; Ling Liu; Ying Shi; Yuan Wang; Menglong Wang; Tao Zeng; Wang Zhen; Yao Xu; Lei Shi; Jianfang Liu; Huimin Jiang; Di Ye; Yingzhong Lin; Jun Wan; Qingwei Ji
Journal:  EBioMedicine       Date:  2018-09-15       Impact factor: 8.143

7.  Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.

Authors:  Yunyan Chen; Mengfei Guo; Ding Qu; Yuping Liu; Jian Guo; Yan Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.